Wed, February 28, 2024
Tue, February 27, 2024
Mon, February 26, 2024
Fri, February 23, 2024

Brian Cheng Maintained (ALLO) at Buy with Decreased Target to $8 on, Feb 27th, 2024


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-8-on-feb-27th-2024.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Brian Cheng of JP Morgan, Maintained "Allogene Therapeutics, Inc." (ALLO) at Buy with Decreased Target from $9 to $8 on, Feb 27th, 2024.

Brian has made no other calls on ALLO in the last 4 months.



There are 4 other peers that have a rating on ALLO. Out of the 4 peers that are also analyzing ALLO, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Schmidt of "Guggenheim" Downgraded from Strong Buy to Hold on, Friday, January 5th, 2024
  • Reni Benjamin of "JMP Securities" Downgraded from Buy to Hold on, Friday, January 5th, 2024


These are the ratings of the 2 analyists that currently disagree with Brian


  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $10 on, Friday, January 19th, 2024
  • Samantha Semenkow of "Citigroup" Initiated at Strong Buy and Held Target at $7 on, Friday, December 8th, 2023

Publication Contributing Sources